×

What are you searching for?




Markets

4 Min read

MICROBIOME BIOTECH FIRM GENOME & COMPANY AWAIT FINAL WORD BEFORE IPO ON KOSDAQ

Published On 03 Dec 2020 10:28 AM


SHARE THIS ARTICLE  


  • Still waiting to go public with its initial public offering (IPO) at tech-intensive KOSDAQ later this year, Genome & Company laid out the biotech firm's various business models and oncoming visions focusing on its microbiome-based immuno-oncology expertise at its IR event on Thursday.
  • Founded back in 2015, the bio company has strong line-ups in discovering and developing innovative therapeutics in immuno-oncology, ma....


    Tags : Genome & company, Microbiome R&D, top microbiome Biotech Company, kosdaq, konex,
    SHARE THIS ARTICLE  

Leave a comment 

comments (0)